Popular Articles
CD&R carves out Hologic’s medical aesthetic treatment unit in $205m deal
Clayton, Dubilier & Rice has agreed to buy Cynosure, the medical aesthetics systems manufacturer, owned by Hologic for $205m.
Real estate secondaries: Deals where ‘both parties walk away happy’
Some investors are hesitant to get on board with the real estate secondaries market, despite enviable growth year-on-year and the evident opportunity for value on both sides of deals.
GHO Capital pulls in €975m to close Europe’s ‘largest healthcare fund’
GHO Capital Partners has raised €975m for the final close of its second fund, which it claims is the largest ever private equity fund dedicated to European healthcare market.
Advent to build up hair care brand following Olaplex buyout
Alternative assets giant Advent International has agreed to buy professional hair care brand Olaplex.
Baring PE Asia to buy Lumenis in $1bn-plus deal, a year after courting from...
Baring Private Equity Asia has agreed a buyout of laser-based medical device maker Lumenis from XIO in a deal which valued the company at more than $1bn.
New Cortec PE fund biggest winner from latest Texas CDRS pension commitments
The Texas County & District Retirement System has made $91.25m of capital commitments to alternative asset funds in November.
Hamilton Lane bolsters leadership team with trio of appointments
Global private equity firm Hamilton Lane has announced a series of senior promotions to support its leadership team
Ex-Stanhope Capital execs land $600m in launch of new firm Eighteen48 Partners
A trio of former Stanhope Capital execs have secured more than $600m for the launch of new investment house Eighteen48 Partners.
Hedge fund Two Sigma builds private equity power with $1.2bn debut Sightway Capital fund...
Hedge fund Two Sigma has raised $1.2bn for its first private equity fund through its Sightway Capital investment unit.
Balance Point already near goal for new fundraise, just a year after $380m Fund...
Balance Point Capital is well on the way to its goal for its newest flagship fundraise, just a year after smashing the target of its predecessor vehicle through a $380m close.
